KREUTER, Michael, JANDOVÁ, Ilona, MOINZADEH, Pia und HUNZELMANN, Nicolas, 2023. Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis. Freiburg: Universität.
Elsevier - Harvard (with titles)Kreuter, M., Jandová, I., Moinzadeh, P., Hunzelmann, N., 2023. Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis. Universität, Freiburg. https://doi.org/10.1093/rheumatology/kead023
American Psychological Association 7th editionKreuter, M., Jandová, I., Moinzadeh, P., & Hunzelmann, N. (ca. 2023). Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis [Cd]. Universität. https://doi.org/10.1093/rheumatology/kead023
Springer - Basic (author-date)Kreuter M, Jandová I, Moinzadeh P, Hunzelmann N (2023) Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Kreuter, Michael/ Jandová, Ilona/ Moinzadeh, Pia/ Hunzelmann, Nicolas, Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis, Freiburg 2023.